A case of enoxaparin-related spontaneous retroperitoneal hematoma in an elderly patient

Year 2019, Volume: 36 Issue: 2, 63 - 65, 25.12.2019

Mahmut Ulubay

Abstract

Enoxaparin is a low molecular weight heparin and the most commonly used antithrombotic agent worldwide. However, this is also leading to increasing incidences of complications. One such complication is spontaneous retroperi-toneal hematoma. The aim of the present study is to evaluate spontaneous ret-roperitoneal hematoma associated with enoxaparin use in an 86-year-old man hospitalized for seven days with a diagnosis of chronic obstructive pulmonary disease. The usage of enoxaparin with antiplatelet agents increased the risk of bleeding in an 86-year-old patient. The usage of combination of enoxaparin and antiplatelet medications should be paid more attention.

Keywords

Enoxaparin , hematoma , heparin , kidney

References

• Daliakopoulos, S.I., 2011. Spontaneous retroperitoneal hematoma: A rare devastating clinical entity of a pleiada of less common origins. Surgery Tech. Case Rep. 3, 8-9.
• Vaya, A., Mira, Y., Aznar, J., 2003. Enoxaparin-related fatal spontaneous retroperitoneal hematoma in the elderly. Thromb. Res. 110, 69-70.
• Ernits, M., Mohan, P.S., Fares, L.G., Hardy, H., 2005. A retroperitoneal bleed induced by enoxaparin therapy. Am. Surg. 71, 430-433.
• Lissoway, J., Booth, A., 2010. Fatal retroperitoneal hematoma after enoxaparin administration in a patient with paroxysmal atrial flutter. Am. J. Health Syst. Pharm. 67, 806-809.
• Haq, M., Taimur, S., Khan, S., Rahman, M., 2010. Retroperitoneal hematoma following enoxaparin treatment in an elderly woman- A case report. J. Cardiol. 3, 94-97.